PureTech Healthの空売り状況は、投資家がPureTech Healthの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

PureTech Health (NASDAQ:PRTC) 株価情報, 空売り情報

PureTech Health

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

PureTech Health plc - American Depositary Shares

PureTech Health PLC

WIIM

ZYME

Zymeworks shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight and announced a price target of $18.

QURE

UniQure shares are trading higher after Stifel maintained a Buy rating on the stock and raised its price target from $12 to $32.

Trading Ideas

BROS

Watching Dutch Bros; Shares Move Higher Following CNBC Mention

Investors with a lot of money to spend have taken a bullish stance on Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ULTA, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Ulta Beauty.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $101,660, and 9, calls, for a total amount of $1,012,847.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $520.0 for Ulta Beauty during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Ulta Beauty's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Ulta Beauty's significant trades, within a strike price range of $200.0 to $520.0, over the past month.
<h3>Ulta Beauty Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734377432_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ULTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$28.5</td>
<td>$28.4</td>
<td>$28.4</td>
<td>$470.00</td>
<td>$193.1K</td>
<td align="right">698</td>
<td align="right">70</td>
</tr>
<tr>
<td>ULTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$31.5</td>
<td>$29.7</td>
<td>$29.71</td>
<td>$400.00</td>
<td>$168.0K</td>
<td align="right">455</td>
<td align="right">182</td>
</tr>
<tr>
<td>ULTA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$51.4</td>
<td>$48.1</td>
<td>$49.2</td>
<td>$400.00</td>
<td>$147.6K</td>
<td align="right">197</td>
<td align="right">30</td>
</tr>
<tr>
<td>ULTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$26.5</td>
<td>$23.9</td>
<td>$26.07</td>
<td>$400.00</td>
<td>$129.9K</td>
<td align="right">455</td>
<td align="right">100</td>
</tr>
<tr>
<td>ULTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$33.2</td>
<td>$27.8</td>
<td>$30.5</td>
<td>$400.00</td>
<td>$124.9K</td>
<td align="right">455</td>
<td align="right">204</td>
</tr>
</tbody>
</table>

<h3>About Ulta Beauty</h3>
With 1,385 stores at the end of fiscal 2023 and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the US. The firm offers makeup (41% of 2023 sales), fragrances, skin care (19% of sales), and hair care products (19% of sales), and bath and body items. Ulta offers private-label products and more than 600 individual brands. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Having examined the options trading patterns of Ulta Beauty, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Ulta Beauty</h3>
<ul>
<li>Currently trading with a volume of 483,691, the ULTA's price is down by 0.0%, now at $424.11. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 87 days.</li>
</ul>
<h3>What Analysts Are Saying About Ulta Beauty</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $418.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on Ulta Beauty, which currently sits at a price target of $410. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Ulta Beauty, maintaining a target price of $360. 
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Ulta Beauty, which currently sits at a price target of $390. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Ulta Beauty with a target price of $450. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Ulta Beauty with a target price of $480. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Ulta Beauty, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

ULTA

Check Out What Whales Are Doing With ULTA

Deep-pocketed investors have adopted a bullish approach towards Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MSFT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 107 extraordinary options activities for Microsoft. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 42% leaning bullish and 42% bearish. Among these notable options, 24 are puts, totaling $1,438,204, and 83 are calls, amounting to $10,813,114.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $700.0 for Microsoft during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Microsoft stands at 5033.26, with a total volume reaching 95,875.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Microsoft, situated within the strike price corridor from $200.0 to $700.0, throughout the last 30 days.
<h3>Microsoft Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734377427_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$47.7</td>
<td>$46.9</td>
<td>$47.22</td>
<td>$440.00</td>
<td>$708.3K</td>
<td>4.4K</td>
<td>153</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$8.15</td>
<td>$7.95</td>
<td>$7.95</td>
<td>$445.00</td>
<td>$461.3K</td>
<td>3.1K</td>
<td>12.1K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$60.45</td>
<td>$57.85</td>
<td>$60.4</td>
<td>$500.00</td>
<td>$302.0K</td>
<td>2.1K</td>
<td>56</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$252.5</td>
<td>$251.5</td>
<td>$251.87</td>
<td>$200.00</td>
<td>$251.8K</td>
<td>13</td>
<td>10</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$16.6</td>
<td>$16.35</td>
<td>$16.49</td>
<td>$515.00</td>
<td>$247.5K</td>
<td>4.4K</td>
<td>156</td>
</tr>
</tbody>
</table>

<h3>About Microsoft</h3>
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
<h3>Microsoft's Current Market Status</h3>
<ul>
<li>Trading volume stands at 9,347,817, with MSFT's price down by -0.12%, positioned at $446.75.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 43 days.</li>
</ul>
<h3>What The Experts Say On Microsoft</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $510.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for Microsoft, targeting a price of $510. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Microsoft, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

MSFT

Looking At Microsoft's Recent Unusual Options Activity

High-rolling investors have positioned themselves bullish on Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in OKTA often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Okta. This is not a typical pattern.
The sentiment among these major traders is split, with 36% bullish and 18% bearish. Among all the options we identified, there was one put, amounting to $25,900, and 10 calls, totaling $388,572.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $87.5 for Okta, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Okta stands at 913.2, with a total volume reaching 1,842.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Okta, situated within the strike price corridor from $70.0 to $87.5, throughout the last 30 days.
<h3>Okta Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734377422_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OKTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.95</td>
<td>$5.95</td>
<td>$5.95</td>
<td>$80.00</td>
<td>$74.3K</td>
<td>851</td>
<td align="right">132</td>
</tr>
<tr>
<td>OKTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/10/25</td>
<td>$3.3</td>
<td>$3.0</td>
<td>$3.29</td>
<td>$84.00</td>
<td>$69.2K</td>
<td>18</td>
<td align="right">305</td>
</tr>
<tr>
<td>OKTA</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/24/25</td>
<td>$4.25</td>
<td>$3.85</td>
<td>$4.02</td>
<td>$84.00</td>
<td>$40.1K</td>
<td>161</td>
<td align="right">100</td>
</tr>
<tr>
<td>OKTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$16.4</td>
<td>$14.65</td>
<td>$15.65</td>
<td>$70.00</td>
<td>$39.1K</td>
<td>354</td>
<td align="right">25</td>
</tr>
<tr>
<td>OKTA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.25</td>
<td>$2.17</td>
<td>$2.17</td>
<td>$87.50</td>
<td>$33.0K</td>
<td>1.4K</td>
<td align="right">360</td>
</tr>
</tbody>
</table>

<h3>About Okta</h3>
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Following our analysis of the options activities associated with Okta, we pivot to a closer look at the company's own performance.
<h3>Okta's Current Market Status</h3>
<ul>
<li>With a volume of 2,134,633, the price of OKTA is up 2.85% at $84.33. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 72 days.</li>
</ul>
<h3>What Analysts Are Saying About Okta</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $100.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Hold rating for Okta, targeting a price of $100. 
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Neutral rating for Okta, targeting a price of $90. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $101. 
&#x2A; An analyst from BMO Capital persists with their Market Perform rating on Okta, maintaining a target price of $105. 
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on Okta, maintaining a target price of $107. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Okta options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

OKTA

Behind the Scenes of Okta's Latest Options Trends

Planet Labs shares are trading higher after Citigroup maintained a Buy rating on the stock and raised its price target from $4.05 to $5.

Mercurity Fintech shares are trading higher after the company announced a joint venture to expand into AI hardware intelligent manufacturing and support liquid cooling solutions for AI servers.

Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) has surged past the $4,000 milestone again, fueled by widespread market optimism and unprecedented inflows into <a href="https://www.benzinga.com/money/what-is-ethereum-etf#:~:text=All%2010%20Items-,What%20Is%20an%20Ethereum%20ETF%3F,owning%20the%20digital%20asset%20itself.">ETH-focused ETFs</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$4,065.94&nbsp;</td>
<td>$489.6 billion</td>
<td>+4.2%&nbsp;</td>
<td>+6.5%&nbsp;</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$106,464.31</td>
<td>$2.1 trillion</td>
<td>+3.1%&nbsp;</td>
<td>+9.4%&nbsp;</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td> $2.47</td>
<td>$141.8 billion</td>
<td>+2.1%&nbsp;</td>
<td>+3%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With prices trading around 5% higher on Monday, crypto trader DonAlt tweeted,
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> &#x1f440; <a href="https://t.co/eanzXmw007">pic.twitter.com/eanzXmw007</a>
&mdash; DonAlt (@CryptoDonAlt) <a href="https://twitter.com/CryptoDonAlt/status/1868718017850515753?ref_src=twsrc%5Etfw">December 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
SmileyCapital <a href="https://x.com/smileycapital/status/1868712269028409594">shared with</a> his followers that now is an opportune moment to buy ETH, suggesting $4,000 might be "the cheapest ETH you'll see for a very long time." 
He boldly predicts that Ethereum could soon surpass Bitcoin in prominence.
Similarly, trader McKenna <a href="https://x.com/Crypto_McKenna/status/1868708705430389015">anticipates</a> a strong "institutional narrative and FOMO" surrounding Ethereum spot ETFs as Q1 2025 approaches. 
He noted that the year-end surge in institutional interest signals a trend likely to persist. 
Crypto analyst Wolf echoed these sentiments, stating that no other chart currently shows as much explosive potential as Ethereum.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I challenge you to find a chart right now with more potential to explode than <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a>. There is none. <a href="https://t.co/5JvCvkrE6M">pic.twitter.com/5JvCvkrE6M</a>
&mdash; Wolf &#x1f43a; (@IamCryptoWolf) <a href="https://twitter.com/IamCryptoWolf/status/1868706773768839220?ref_src=twsrc%5Etfw">December 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: SoSoSo Value data shows Ethereum Spot ETFs posting $855 million in net inflows between Dec. 9 and 13, marking a record high. 
BlackRock's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETHA#NASDAQ">ETHA</a>) ETF saw $523 million in weekly inflows, while Fidelity&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FETH#NASDAQ">FETH</a>) ETF followed with $259 million in net inflows. 
Total net assets stood at $13.8 billion as of Dec.13.
IntoTheBlock data shows large transaction volume increasing by 3.8% and daily active addresses dropping by 3.7%. 
Exchanges netflows are down by 538.9%. 
Around 96% ETH holders are in profit, 4% are at breakeven.
Coinglass data shows Ethereum short liquidations of $56.8 million at the highest level since Aug. 5.
Open interest spiked 9.5% to $29.7 billion in a single day, while ETH derivatives trading volume surged 124%.
Community News: SpotOnChain <a href="https://platform.spotonchain.ai/en/entity/278">data</a> shows Justin Sun withdrawing 52,905 ETH (worth $209 million) from Lido Finance approximately 15 hours ago, reporting a 29% ROI and a profit of $349 million on his ETH investments.
Following Ethereum's recent rally to $4,000, Sun sold 29,920 ETH (valued at $119.7 million).
What&#8217;s Next: Ethereum's recent momentum reflects strong institutional interest, elevated trading activity and key movements from high-profile investors, adding fuel to <a href="https://www.benzinga.com/money/ethereum-eth-price-predictions">its bullish outlook</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42490266/bitcoin-to-180000-ethereum-over-6000-solana-to-500-vanecks-2025-crypto-predictions">Bitcoin To $180,000, Ethereum Over $6,000, Solana To $500: VanEck&#8217;s 2025 Crypto Predictions</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$ETH

$XRP

ETHA

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

Ethereum Price Soars Past $4,000: What Is Going On With ETH?

As digital assets continue to reshape financial systems, custody solutions are emerging as a central concern for <a href="https://www.benzinga.com/topic/institutional-investors">retail and institutional investors</a>. 
During a panel at the recent Benzinga Future of Digital Assets conference, industry leaders explored the evolving role of custody in safeguarding digital assets, balancing security with accessibility, and building trust through transparency.
Kevin Maloney, CEO of iTrustCapital, explained how his platform accommodates over 55,000 users by collaborating with custodians such as Fire Blocks and Coinbase Prime. Our clients want safety and peace of mind without the technical burden of managing their keys," Maloney explained. The company employs a blend of offline cold storage and controlled online withdrawal access, providing security and functionality.
See Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/24/12/42513306/elon-musks-tesla-nearly-5-times-more-expensive-than-industry-average-stock-surges-over-60-since-election">Elon Musk&#8217;s Tesla Nearly 5 Times More Expensive Than Industry Average: Stock Surges Over 60% Since Election</a>
The ability to meet user demands while maintaining robust safeguards has become an essential focus for custody providers. As Maloney described, this approach ensures assets remain secure while accommodating the needs of users moving funds in and out regularly.
<h3 class="wp-block-heading">Building Trust Through Transparency</h3>
Paul Giordano, vice president of digital asset management at Marathon Digital Holdings, highlighted how public companies depend on audited, federally chartered banks to store digital assets. "Transparency and accountability are non-negotiable. It's the foundation of our strategy," Giordano said.
Maloney proposed adopting regular spot checks for custodians to bolster trust. "Annual audits don't go far enough. Investors need to see proof of reserves more frequently to have real confidence," he stated.
The panel also addressed past industry failures and their lessons. Giordano pointed to rehypothecation, where assets are repeatedly pledged as collateral, as a critical risk. "This practice creates instability and can lead to systemic failures during market downturns," he warned.
<h3 class="wp-block-heading">Accountability as a Path Forward</h3>
While custody technology has become more reliable, the panelists agreed that human errors and unethical practices often create the most significant risks. Ben Spiegelman, vice president at Figment, emphasized this point: &#8220;The real issues have been about bad actors misusing assets rather than technical vulnerabilities."
Looking to the future, the panelists expressed optimism about greater collaboration between traditional financial institutions and digital asset providers. Giordano remarked on the involvement of established players like State Street, which he believes could help bring more clarity and order to the industry.
Maloney also emphasized education as a vital component of adoption. "The more transparent and clear we are, the easier it will be for new participants to feel confident in this space," he said.
By addressing past missteps and prioritizing transparency, custody providers are laying the groundwork for a more secure and trustworthy digital asset ecosystem. As Spiegelman aptly summarized, "Building trust is essential to encouraging adoption and delivering meaningful value to users."
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/12/42513807/trump-says-softbanks-100b-commitment-to-us-is-monumental-demonstration-of-confidence-in-americas-future">Trump Says SoftBank&#8217;s $100B Commitment To US Is &#8216;Monumental Demonstration Of Confidence In America&#8217;s Future&#8217;</a></li>
</ul>
Image: Shutterstock

Blockchain Guardians: Marathon Digital VP, Other Industry Leaders Push For Transparency In Custody

ADNT

Adient Plc shares are trading lower. Wells Fargo downgraded its rating on the stock from Overweight to Equal-Weight and lowered its price target from $27 to $20.

Kosmos Energy shares are trading lower after Mizuho cut its price target on the stock from $5 to $4.

Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) shares are trading higher by 6.68% to $15.33 during Monday&#8217;s session. The stock has gained some 11% since last Wednesday&#8217;s session after Benchmark analyst Mickey Legg <a href="https://www.benzinga.com/analyst-ratings/initiation/24/12/42408445/rivian-stock-surges-over-11-after-analyst-says-it-is-well-positioned-to-gain-significant-share">initiated coverage</a> with a Buy rating and an $18 price target.
Goldman Sachs also predicts <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42467808/rivian-tesla-will-drive-autonomous-vehicle-progress-in-2025-goldman-sachs">significant advancements</a> in autonomous vehicles by 2030, with Level 3 AVs comprising 10% of new vehicle sales and over 2 million fully autonomous Level 4/5 vehicles sold annually.
The firm maintained Neutral ratings for Tesla Inc and Rivian, citing Tesla's robotaxi plans and regulatory challenges, alongside Rivian's potential to monetize its Autonomy+ driver-assist platform.
Read Also: <a href="https://www.benzinga.com/etfs/specialty-etfs/24/12/42508800/frances-credit-rating-downgrade-sparks-market-unease-public-finances-will-be-materially-weaker">France&#8217;s Credit Rating Downgrade Sparks Market Unease: &#8216;Public Finances Will Be Materially Weaker&#8217;</a>
What To Know: Analyst Mickey Legg expressed optimism about Rivian's ability to capture significant EV market share. Per Barron's, Legg highlighted expected domestic EV production growth starting in 2025, driven by lower prices and improved charging infrastructure.
Rivian offers the high-end R1T truck and R1S SUV, both starting around $70,000~ and plans a $45,000 R2 SUV in 2026 to compete with Tesla's Model Y. A cheaper R3 crossover is also planned.
Though unprofitable, Rivian produced 13,157 vehicles in the third quarter and forecasts over 50,000 annual deliveries. With $6.7 billion in cash and a Volkswagen partnership, investors await its next moves.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42505162/trump-reportedly-considering-executive-order-to-establish-strategic-bitcoin-reserve">Trump Reportedly Considering Executive Order To Establish Strategic Bitcoin Reserve</a>
<h2 class="wp-block-heading">How To Buy RIVN Stock</h2>
By now you're likely curious about how to participate in the market for Rivian Automotive &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RIVN has a 52-week high of $24.62 and a 52-week low of $8.26.

RIVN

What's Going On With Rivian (RIVN) Stock?

Phillips 66 shares are trading lower. The company set its 2025 capital budget and announced an agreement to sell DCP GCX Pipeline LLC.

PARR

Par Pacific shares are trading lower after Mizuho downgraded its rating on the stock from Outperform to Neutral and lowered its price target from $26 to $22.

Micron shares are trading higher ahead of Wednesday's earnings report.

SUPV

Grupo Supervielle shares are trading higher after BOA upgraded its rating from Neutral to Buy on the stock and raised its price target from $11.20 to $15.

Macro Economic Events

Market Summary

Economics

General

AVGO

TSLA

Benzinga Market Summary: Broadcom Continues Higher, Bitcoin Reaches All-Time High, Wedbush Raises Tesla PT

Phunware Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>), once a darling of traders during Donald Trump's 2020 re-election campaign, may be on the verge of a significant technical milestone &#8211; <a href="https://www.benzinga.com/topic/golden-cross">a Golden Cross</a>. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16122459/Screenshot-2024-12-16-at-10.17.24-PM.png" alt="" class="wp-image-694326" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16122459/Screenshot-2024-12-16-at-10.17.24-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16122459/Screenshot-2024-12-16-at-10.17.24-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121624&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Despite recent bearish trends, this potential shift in momentum has sparked renewed interest in the stock.
Read Also: <a href="https://www.benzinga.com/markets/equities/24/11/41767332/trumps-potential-return-to-white-house-sends-ex-president-linked-phunware-stock-upwards-during-p">Trump&#8217;s Potential Return To White House Sends Ex-President Linked Phunware Stock Upwards During Pre-Market Hours</a>
<h2 class="wp-block-heading">PHUN Stock: From Bearish Signals To Bullish Potential</h2>
Phunware&#8217;s current technical indicators paint a grim picture. Its stock price, at $4.39, remains below all major moving averages: the eight-day, 20-day, 50-day and even the 200-day simple moving averages. 
The MACD indicator sits at a negative 0.36, and its RSI of 43.75 reflects ongoing selling pressure.
For now, the technicals remain firmly bearish, signaling a tough road ahead.
But a Golden Cross—a bullish pattern where the 50-day moving average crosses above the 200-day moving average—could mark a turning point. Historically, such events signal a shift from bearish to bullish momentum, attracting traders looking to ride the wave of an uptrend.
<h2 class="wp-block-heading">AI Ambitions: A New Catalyst?</h2>
While its technicals simmer, Phunware is busy reinventing itself. The company <a href="https://www.marketwatch.com/story/phunware-which-soared-as-a-trump-trade-preps-ai-driven-canvassing-tool-1830f7d5">recently</a> announced its development of an AI-powered canvassing tool in collaboration with MyCanvass, a voter-engagement platform founded by Brad Parscale, Trump's former campaign manager. 
The tool aims to provide campaigns with actionable insights on voter sentiment and outreach effectiveness. Interim CEO Stephen Chen describes it as &#8220;AI-powered civic engagement,&#8221; with broad applications beyond politics, including community building and trust enhancement.
Phunware is also betting big on generative AI, with plans to launch a platform by mid-2025. While leadership changes, including the departure of its CEO and CFO, create some uncertainty, Chen insists the company is well-positioned for growth.
<h2 class="wp-block-heading">The Path Ahead</h2>
Phunware's stock may still be navigating bearish waters, but the looming golden cross, coupled with its ambitious AI-driven plans, could breathe new life into this former &#8216;Trump trade.&#8217; 
For now, traders are watching closely to see if technical signals align with the company&#8217;s bold new direction.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41712003/trump-linked-phunwares-leadership-shuffle-continues-cfo-joins-ceo-in-exit-queue">Trump-Linked Phunware&#8217;s Leadership Shuffle Continues: CFO Joins CEO In Exit Queue</a></li>
</ul>
Photo: Shutterstock

Technicals

Signals

Tech

PHUN

Phunware Golden Cross Potential Sparks Fresh Market Interest

Major indexes are higher amid strength in some large-cap tech stocks.

Warning: PRTC is at high risk of performing badly

Healthcare Analyst Khurshid discusses emerging Idiopathic Pulmonary Fibrosis (IPF) drugs, PureTech LYT-100, Pliant Therapeutics Bexotegrast (Bexo) ...

Leerink healthcare analysts hold an analyst/industry conference call

Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on PureTech Health (PRTC – Research Report) on November 19 and set a price target ...

Positive Outlook on PureTech Health's LYT-100 Amid Potential Breakthrough in IPF Treatment

5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)

PureTech Health (PRTC) presented data from the dose escalation phase of its ongoing Phase 1b trial evaluating LYT-200, an anti-galectin-9 monoclona...

PureTech Health presents data from dose escalation phase of LYT-200 trial

PureTech Health (PRTC) announced results from ELEVATE IPF, a Phase 2b randomized, double-blind, active- and placebo-controlled, dose-ranging trial ...

PureTech Health announces ELEVATE IPF trial achieves primary endpoint

BMYMP

MNKD

PLNT

PRTC

PTCHF

RPRX

Press Releases

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

PureTech to Present at CHEST 2024 Annual Meeting

PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting

PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

PureTech to Present at Two Upcoming Investor Conferences

PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer

PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors

PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting

PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024

PureTech's Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial

ABBV

CCCC

IMGN

Abivax

AnaptysBio

Annexon

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Astria Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Celcuity

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

Emergent BioSolutions

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Humacyte

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Kodiak Sciences

MeiraGTx Hldgs

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Opthea Limited - American Depositary Shares

Opthea

Organogenesis Hldgs

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Savara

Tourmaline Bio

Verve Therapeutics

Leerink Partners

Piper Sandler

SVB Leerink

PureTech Health shares are trading higher after the company announced its Phase 2b trial of Deupirfenidone achieved significant lung function preservation.

Comments

PureTech Health

空売り

PureTech Health (NASDAQ:PRTC) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル